Journal of Shanghai Jiao Tong University (Medical Science) ›› 2023, Vol. 43 ›› Issue (4): 507-513.doi: 10.3969/j.issn.1674-8115.2023.04.015
• Review • Previous Articles
MEN Ru(), ZHU Minxia, ZHANG Weiming()
Received:
2022-09-08
Accepted:
2023-02-14
Online:
2023-04-28
Published:
2023-04-28
Contact:
ZHANG Weiming
E-mail:13326393425@163.com;weimingzh1965@163.com
CLC Number:
MEN Ru, ZHU Minxia, ZHANG Weiming. Serum potassium level in maintenance hemodialysis patients and its effect on outcome[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(4): 507-513.
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2023.04.015
1 | KOVESDY C P. Management of hyperkalaemia in chronic kidney disease[J]. Nat Rev Nephrol, 2014, 10(11): 653-662. |
2 | 边佳明, 左力, 赵厚宇, 等. 中国门诊患者高钾血症分布及诊疗现状的流行病学研究[J].中国血液净化, 2020, 19(11): 726-729, 746. |
BIAN J M, ZUO L, ZHAO H Y, et al. Epidemiology and treatment pattern of hyperkalemia among outpatients in China: a descriptive study using an administrative database in China[J]. Chinese Journal of Blood Purification, 2020, 19(11): 726-729, 746. | |
3 | AGAR B U, CULLETON B F, FLUCK R, et al. Potassium kinetics during hemodialysis[J]. Hemodial Int, 2015, 19(1): 23-32. |
4 | BLUMBERG A, ROSER H W, ZENHNDER C, et al. Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium[J]. Nephrol Dial Transplant, 1997, 12(8): 1629-1634. |
5 | KOVESDY C P. Fluctuations in plasma potassium in patients on dialysis[J]. Nephrol Dial Transplant, 2019, 34(Suppl 3): iii19-iii25. |
6 | MERCADAL L, LAMBERT O, COUCHOUD C, et al. Prescription patterns of dialysate potassium and potassium binders and survival on haemodialysis: the French Renal Epidemiology and Information Network registry[J]. Nephrol Dial Transplant, 2021, 36(1): 151-159. |
7 | HE H D, WU J J, LU W, et al. A multicenter study of hemodialysis using individualized dialysate potassium concentrations[J]. Ann Palliat Med, 2021, 10(12): 12218-12229. |
8 | SHIBATA S, UCHIDA S. Hyperkalemia in patients undergoing hemodialysis: its pathophysiology and management[J]. Ther Apher Dial, 2022, 26(1): 3-14. |
9 | BANSAL S, PERGOLA P E. Current management of hyperkalemia in patients on dialysis[J]. Kidney Int Rep, 2020, 5(6): 779-789. |
10 | EPSTEIN M, LIFSCHITZ M D. The unappreciated role of extrarenal and gut sensors in modulating renal potassium handling: implications for diagnosis of dyskalemias and interpreting clinical trials[J]. Kidney Int Rep, 2016, 1(1): 43-56. |
11 | PALMER B F, CLEGG D J. Diagnosis and treatment of hyperkalemia[J]. Cleve Clin J Med, 2017, 84(12): 934-942. |
12 | PUN P H, MIDDLETON J P. Dialysate potassium, dialysate magnesium, and hemodialysis risk[J]. J Am Soc Nephrol, 2017, 28(12): 3441-3451. |
13 | FEIG P U, SHOOK A, STERNS R H. Effect of potassium removal during hemodialysis on the plasma potassium concentration[J]. Nephron, 1981, 27(1): 25-30. |
14 | SANDLE G I, GAIGER E, TAPSTER S, et al. Evidence for large intestinal control of potassium homoeostasis in uraemic patients undergoing long-term dialysis[J]. Clin Sci (Lond), 1987, 73(3): 247-252. |
15 | CUPISTI A, KOVESDY C P, D'ALESSANDRO C, et al. Dietary approach to recurrent or chronic hyperkalaemia in patients with decreased kidney function[J]. Nutrients, 2018, 10(3): 261. |
16 | United States Renal Data System. 2021 USRDS Annual Data Report: Epidemiology of kidney disease in the United States[EB/OL]. (2023-01-08) [2022-06-01]. https://adr.usrds.org/2021. |
17 | 赵新菊, 甘良英, 牛庆雨, 等. 中国血液透析患者死亡原因及特点分析: DOPPS研究的启示[J].中国血液净化, 2022, 21(2): 89-93. |
ZHAO X J, GAN L Y, NIU Q Y, et al. The cause of death and its related information in hemodialysis patients in China: enlightenment from the DOPPS study[J]. Chinese Journal of Blood Purification, 2022, 21(2): 89-93. | |
18 | 黄耀禹, 王静, 王宁宁, 等. 维持性血液透析患者高钾血症及其反复发作的相关因素[J].中华医学杂志, 2021, 101(42): 3484-3489. |
HUANG Y Y, WANG J, WANG N N, et al. Related factors for hyperkalemia and its recurrence in maintenance hemodialysis patients[J]. National Medical Journal of China, 2021, 101(42): 3484-3489. | |
19 | ROSSIGNOL P, LAMIRAL Z, FRIMAT L, et al. Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey[J]. Nephrol Dial Transplant, 2017, 32(12): 2112-2118. |
20 | HOPPE L K, MUHLACK D C, KOENIG W, et al. Association of abnormal serum potassium levels with arrhythmias and cardiovascular mortality: a systematic review and meta-analysis of observational studies[J]. Cardiovasc Drugs Ther, 2018, 32(2): 197-212. |
21 | KARABOYAS A, ZEE J, BRUNELLI S M, et al. Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the dialysis outcomes and practice-patterns study (DOPPS)[J]. Am J Kidney Dis, 2017, 69(2): 266-277. |
22 | KARABOYAS A, ROBINSON B M, JAMES G, et al. Hyperkalemia excursions are associated with an increased risk of mortality and hospitalizations in hemodialysis patients[J]. Clin Kidney J, 2020, 14(7): 1760-1769. |
23 | 赵新菊, 牛庆雨, 甘良英, 等. 基于DOPPS研究分析中国血液透析患者高钾血症的患病率及相关影响因素[J]. 中国血液净化, 2021, 20(3): 145-150, 156. |
ZHAO X J, NIU Q Y, GAN L Y, et al. The prevalence and risk factors of hyperkalemia in Chinese hemodialysis patients based on the China Dialysis Outcomes and Practice Patterns Study[J]. Chinese Journal of Blood Purification, 2021, 20(3): 145-150, 156. | |
24 | FERRARO P M, BOLIGNANO D, AUCELLA F, et al. Hyperkalemia excursions and risk of mortality and hospitalizations in hemodialysis patients: results from DOPPS-Italy[J]. J Nephrol, 2022, 35(2): 707-709. |
25 | KOVESDY C P, REGIDOR D L, MEHROTRA R, et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients[J]. Clin J Am Soc Nephrol, 2007, 2(5): 999-1007. |
26 | YUSUF A A, HU Y, SINGH B, et al. Serum potassium levels and mortality in hemodialysis patients: a retrospective cohort study[J]. Am J Nephrol, 2016, 44(3): 179-186. |
27 | TAFESSE E, HURST M, SUGRUE D, et al. Serum potassium as a predictor of adverse clinical outcomes in patients with increasing comorbidity burden[J]. Eur Heart J Qual Care Clin Outcomes, 2022, 8(1): 61-69. |
28 | DE ROOIJ E N M, DEKKER F W, LE CESSIE S, et al. Serum potassium and mortality risk in hemodialysis patients: a cohort study[J]. Kidney Med, 2022, 4(1): 100379. |
29 | PUN P H, LEHRICH R W, HONEYCUTT E F, et al. Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics[J]. Kidney Int, 2011, 79(2): 218-227. |
30 | LEE S, KANG E, YOO K D, et al. Lower serum potassium associated with increased mortality in dialysis patients: a nationwide prospective observational cohort study in Korea[J]. PLoS One, 2017, 12(3): e0171842. |
31 | TORLÉN K, KALANTAR-ZADEH K, MOLNAR M Z, et al. Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort[J]. Clin J Am Soc Nephrol, 2012, 7(8): 1272-1284. |
32 | OHNISHI T, KIMACHI M, FUKUMA S, et al. Postdialysis hypokalemia and all-cause mortality in patients undergoing maintenance hemodialysis[J]. Clin J Am Soc Nephrol, 2019, 14(6): 873-881. |
33 | HESSELS L, HOEKSTRA M, MIJZEN L J, et al. The relationship between serum potassium, potassium variability and in-hospital mortality in critically ill patients and a before-after analysis on the impact of computer-assisted potassium control[J]. Crit Care, 2015, 19(1): 4. |
34 | ENGELHARDT L J, BALZER F, MÜLLER M C, et al. Association between potassium concentrations, variability and supplementation, and in-hospital mortality in ICU patients: a retrospective analysis[J]. Ann Intensive Care, 2019, 9(1): 100. |
35 | LOMBARDI G, GAMBARO G, FERRARO P M. Serum potassium variability is associated with increased mortality in a large cohort of hospitalized patients[J]. Nephrol Dial Transplant, 2022, 37(8): 1482-1487. |
36 | XU Q D, XU F H, FAN L, et al. Serum potassium levels and its variability in incident peritoneal dialysis patients: associations with mortality[J]. PLoS One, 2014, 9(1): e86750. |
37 | LI S H, XIE J T, LONG H B, et al. Time-averaged serum potassium levels and its fluctuation associate with 5-year survival of peritoneal dialysis patients: two-center based study[J]. Sci Rep, 2015. 5: 15743. |
38 | DASHPUTRE A A, POTUKUCHI P K, SUMIDA K, et al. Predialysis potassium variability and postdialysis mortality in patients with advanced CKD[J]. Kidney Int Rep, 2021, 6(2): 366-380. |
39 | BUEMI M, ALOISI E, COPPOLINO G, et al. The effect of two different protocols of potassium haemodiafiltration on QT dispersion[J]. Nephrol Dial Transplant, 2005, 20(6): 1148-1154. |
40 | MORRISON G, MICHELSON E L, BROWN S, et al. Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients[J]. Kidney Int, 1980, 17(6): 811-819. |
41 | SANTORO A, MANCINI E, LONDON G, et al. Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal[J]. Nephrol Dial Transplant, 2008, 23(4): 1415-1421. |
42 | ABUELO J G. Low dialysate potassium concentration: an overrated risk factor for cardiac arrhythmia?[J]. Semin Dial, 2015, 28(3): 266-275. |
43 | JADOUL M, THUMMA J, FULLER D S, et al. Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study[J]. Clin J Am Soc Nephrol, 2012, 7(5): 765-774. |
44 | FERREY A, YOU A S, KOVESDY C P, et al. Dialysate potassium and mortality in a prospective hemodialysis cohort[J]. Am J Nephrol, 2018, 47(6): 415-423. |
45 | ADROGUÉ H J, MADIAS N E. Changes in plasma potassium concentration during acute acid-base disturbances[J]. Am J Med, 1981, 71(3): 456-467. |
46 | HEGUILÉN R M, SCIURANO C, BELLUSCI A D, et al. The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients[J]. Nephrol Dial Transplant, 2005, 20(3): 591-597. |
47 | ALHOSAINI M, LEEHEY D J. Magnesium and dialysis: the neglected cation[J]. Am J Kidney Dis, 2015, 66(3): 523-531. |
48 | MCGILL R L, WEINER D E. Dialysate composition for hemodialysis: changes and changing risk[J]. Semin Dial, 2017, 30(2): 112-120. |
49 | PALMER B F, CARRERO J J, CLEGG D J, et al. Clinical management of hyperkalemia[J]. Mayo Clin Proc, 2021, 96(3): 744-762. |
50 | SHERMAN R A, HWANG E R, BERNHOLC A S, et al. Variability in potassium removal by hemodialysis[J]. Am J Nephrol, 1986, 6(4): 284-288. |
[1] | WANG Anjun, LIU Ningning. Efficacy of radiotherapy in patients with rectal cancer undergoing chemotherapy and surgery: a retrospective study based on the SEER database [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(3): 320-332. |
[2] | LI Fang, LI Kaiyang, WANG Jue, YAN Ruiyang, SHEN Hui, LIU Min. Expression and clinical significance of PLA2G2A in kidney renal papillary cell carcinoma [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(2): 152-161. |
[3] | HOU Shumin, SHAO Jingbo. Research progress in clinical characteristics, diagnosis and prognosis of TdT-negative lymphoblastic lymphoma/acute lymphoblastic leukemia [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(1): 120-124. |
[4] | QIU Jiahui, CAI Qianqian, YANG Yan, CHENG Feichi, QIU Zhengjun, HUANG Chen. Value of combined perineural lymphovascular invasion and tumor-stroma ratio in guiding the prognosis of colorecatal cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(8): 1070-1080. |
[5] | WEI Xuemin, GAO Chengjin. Research progress of clinical application of ASPECT score in acute ischemic stroke [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(7): 919-924. |
[6] | ZHU Tianyu, ZONG Chunyan, XU Shiqiong, GE Shengfang, FAN Xianqun, JIA Renbing. Relationship between histopathological features, Ki-67 expression and prognosis of conjunctival melanoma [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(5): 617-623. |
[7] | XIANG Han, XIANG Wu, ZHANG Weiguo. Research progress in acquired cystic disease-associated renal cell carcinoma [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(5): 680-684. |
[8] | Aiyong YU, Yingchun ZHAO, Xiaochun PAN, Kegui ZHOU, Yuwu ZHAO, Lei GU. Characteristics of cerebral perfusion in patients with limb shaking-transient ischemic attacks with different blood pressure variations [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2022, 42(2): 178-184. |
[9] | Zhengwen XING, Ying WU, Xueli WANG, Qingyu WANG, Wenting WANG, Zhi LI, Bin ZHANG, Jing JIN. Analysis of clinicopathologic features and prognosis of eight children with granulosa cell tumor of ovary [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2022, 42(2): 192-196. |
[10] | ZHAO Xue, DONG Chunyan. Correlation of WD 40 repeat 43 expression in lung adenocarcinoma and its effect on paclitaxel-resistance of cells [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(12): 1656-1665. |
[11] | GU Shuneng, WU Pengfei, WU Yurong. Diagnosis and treatment of congenital vascular ring: prenatal and postnatal [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(11): 1620-1626. |
[12] | Xuemei LU, Lan CHEN. Application of modified Nutrition Risk in the Critically Ill score to critically ill elderly patients [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2022, 42(1): 16-20. |
[13] | Bei-bei XUAN, Sai-nan GONG, Jia-li LIU, Quan QUAN, Yu MENG, Xiao-ling MU. Expression and clinical significance of DNA polymerase θ in endometrial cancer [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(9): 1207-1214. |
[14] | Lei XIONG, Qian YI, Ming-fang XU, Jian CHEN. Expression and prognosis analysis of MRPL12 in lung adenocarcinoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1033-1040. |
[15] | Sheng CHEN, Zhi-long YAN, Ye-ming WU, Min XU, Song GU, Jing MA. Expression and clinical significance of HIF-1α/SHH signaling pathway in neuroblastoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1056-1061. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||